Riskpilot← Back to searchSign inGet full accessEndometrix AB
ABActiveOrg 5591844815Vattugatan 6Computer programming activities · NACE 6210Est. 20181 employees
Revenue 2024
SEK 0
EBITDA margin
—
-7% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
SEK -16K
-7% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -16K | -7% |
| Net profit | SEK -16K | -7% |
| Total assets | SEK 73K | -21% |
| Equity | SEK 72K | -18% |
| Employees | 1 | — |
Legal name
Endometrix AB
Org number
5591844815
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
10 december 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva e-hälsotjänster, samt därmed förenlig verksamhet, inom gynekologisk hälso- och sjukvård i syfte att öka livskvaliteten för användarna.
Address
Vattugatan 6
Email
info@endo-metrix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 38 | 13 | 1 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −202 | −37 | −10 | −15 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −202 | −37 | −10 | −15 | −16 |
| Net financials | — | −1 | — | — | — |
| Profit before tax | −202 | −38 | −10 | −15 | −16 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −202 | −38 | −10 | −15 | −16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 31 | 56 | 57 | 92 | 73 |
| Equity | 31 | 43 | 53 | 88 | 72 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 13 | 4 | 4 | 1 |
| Total debt | — | 13 | 4 | 4 | 1 |
EBITDA margin
-1600000.0%
This company
15.8%
Market median
-10126682% vs market
20202024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
-22.2%
This company
18.4%
Market median
-221% vs market
20202024
Net profit margin
-1600000.0%
This company
8.1%
Market median
-19753186% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
SS Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
MF Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Endometrix AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sushrut Satyanand Shastri | Chief Executive Officer | 0 companies |
| Moa Felicia Linder | Chief Executive Officer | 0 companies |
| Eva Maria Cornelius | Deputy Board Member | 0 companies |
| Vincent Olof Cornelius | Chairman | 0 companies |
| Paul Jan Beatus | Board of Directors | 0 companies |